European Union fines biotech big Illumina $475 million for taking up cancer-screening firm Grail with out approval
BRUSSELS — European Union fines biotech big Illumina $475 million for taking up cancer-screening firm Grail with out approval.
European Union fines biotech big Illumina $475 million for taking up cancer-screening firm Grail with out approval
BRUSSELS — European Union fines biotech big Illumina $475 million for taking up cancer-screening firm Grail with out approval.